Biasiolo A, Pengo V
Department of Cardiology, Padua University School of Medicine, Ex Busonera Hospital, Italy.
Blood Coagul Fibrinolysis. 1993 Jun;4(3):425-8. doi: 10.1097/00001721-199306000-00005.
To explore the possibility of an interaction between platelets and antiphospholipid antibodies and its relationship with thromboembolic events, platelets from six patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis were isolated by gel filtration. Five patients had primary antiphospholipid syndrome and one had a form secondary to systemic lupus erythematosus. Two patients had mild thrombocytopenia. The six platelet membrane eluates contained less than 1.09 GPL units of anticardiolipin antibodies and displayed no lupus anticoagulant activity. Similarly, lysates of disrupted platelets did not show anticardiolipin or lupus anticoagulant activity. These results suggest that antiphospholipid antibodies do not interact with circulating platelets, at least in patients on oral anticoagulant treatment with no evidence of acute thrombosis.
为探讨血小板与抗磷脂抗体之间相互作用的可能性及其与血栓栓塞事件的关系,通过凝胶过滤法从6例患有IgG抗心磷脂抗体、狼疮抗凝物及血栓形成的患者中分离出血小板。5例患者患有原发性抗磷脂综合征,1例继发于系统性红斑狼疮。2例患者有轻度血小板减少症。6份血小板膜洗脱液中抗心磷脂抗体含量低于1.09 GPL单位,且无狼疮抗凝物活性。同样,破碎血小板的裂解物也未显示抗心磷脂或狼疮抗凝物活性。这些结果表明,抗磷脂抗体不与循环血小板相互作用,至少在接受口服抗凝治疗且无急性血栓形成证据的患者中如此。